DASH vs EDIT
DoorDash, Inc. Class A Common Stock (DASH) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DASH and EDIT stock pages for the full models.
Not investment advice.